Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/29/2003US20030099710 Granule modulating hydrogel system
05/29/2003US20030099708 Printing or dispensing a suspension such as three-dimensional printing of dosage forms
05/29/2003US20030099705 Sustained release ranolazine formulations
05/29/2003US20030099704 Controlled release oxycodone compositions
05/29/2003US20030099700 Orodispersible tablets, able to disintegrate in buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60 seconds, containing fexofenadine or its salt in the form of a coated granule, and excipients
05/29/2003US20030099699 Storage stable thyroxine active drug formulations and methods for their production
05/29/2003US20030099698 Storage stable thyroxine active drug formulations and methods for their production
05/29/2003US20030099697 Amphoteric liposomes and their use
05/29/2003US20030099694 Method for the improvement of transport across adaptable semi-permeable barriers
05/29/2003US20030099686 Theobromine with an anti-carcinogenic activity
05/29/2003US20030099678 Method and topical formulation for treating skin conditions associated with aging
05/29/2003US20030099676 Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use
05/29/2003US20030099675 Comprising 9-90% by weight monoglyceride compound, 0.01-90% by weight emulsifier, 0-50% by weight water-insoluble material, 0-90.9% by weight of organic solvent; drug delivery
05/29/2003US20030099674 Comprising porous lyophilized formulation containing at least one taxoid drug, wherein formulation can be readily reconstituted into injectable suspension or emulsion by mixing with water using mild agitation
05/29/2003US20030099668 Comprises loading (transfection) immunogenic DNA oligonucleotides for enhanced lymphocyte response; genetic engineering
05/29/2003US20030099666 Gum resin as a carrier for topical application of pharmacologically active agents
05/29/2003US20030099662 Proteins
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099628 Preventing proliferation of a tumor, using heparinase III; use sequencing heparin-like glycosaminoglycans (HLGAGs), removing active heparan sulfate from a solution, inhibition of angiogenesis
05/29/2003US20030099627 Method for determining modulation of p110delta activity
05/29/2003US20030099626 Mixture of various Aspergillus derived enzymes such as protease, lipase, amylase and cellulase and mineral cofactors such as calcium, zinc, manganese, and magnesium compounds
05/29/2003US20030099614 2-Methoxyestradiol-induced apoptosis in cancer cells
05/29/2003US20030099611 Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection
05/29/2003US20030099609 Canine IL-4 nucleic acid molecules and uses thereof
05/29/2003US20030099606 Iodinating an strong base anion exchange resin with iodine or an iodine compound; abosorbing through the pores of ion exchange resin
05/29/2003US20030099602 Treatment of dental or periodontal diseases, prevention of cardiovascular disorders such as stroke
05/29/2003US20030099600 Metalloproteinase inhibitors for the treatment of respiratory diseases
05/29/2003US20030099599 Antibiotic spray
05/29/2003US20030099596 Treatment of macular edema
05/28/2003EP1314980A2 A system for cell-based screening
05/28/2003EP1314784A1 G-protein coupled receptor LUSTR2 and uses thereof
05/28/2003EP1314741A1 Bispecific anti-CD19 x anti-CD16 antibodies and uses thereof
05/28/2003EP1314733A1 Indole-2-carboxamides as factor Xa inhibitors
05/28/2003EP1314732A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314731A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314729A1 Biologically active 4H-benzo(1,4)oxazin-3-ones
05/28/2003EP1314728A1 Pyridyl and pyrimidinyl imines as intermediates for imidazole derivatives
05/28/2003EP1314726A1 Novel ester or amide derivatives
05/28/2003EP1314723A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1314438A1 Anti-proliferative composition
05/28/2003EP1314435A1 Cosmetic and/or dermatologic active substance preparation
05/28/2003EP1314432A1 Aescin mixtures
05/28/2003EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis
05/28/2003EP1314428A1 Oct preparations
05/28/2003EP1314427A1 Remedial agent for osteoporosis
05/28/2003EP1314426A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1314425A1 Medicinal compositions for preventing or treating heart failure
05/28/2003EP1314424A1 Seamless soft capsule preparations containing dihydrobenzofuran derivatives
05/28/2003EP1314423A1 Medicinal compositions
05/28/2003EP1314417A1 Hair growers
05/28/2003EP1314041A2 Screen for glutamate reuptake inhibitors, stimulators, and modulators
05/28/2003EP1313885A2 Methods of using agents that modulate bone formation and inhibit adipogenesis
05/28/2003EP1313882A2 Diagnosis and treatment of prostate cancer
05/28/2003EP1313853A2 Modulation of fas and fasl expression
05/28/2003EP1313768A2 Antisense oligonucleotides against vr1
05/28/2003EP1313762A2 Suppressor gene
05/28/2003EP1313751A1 New macrolides with antibacterial activity
05/28/2003EP1313749A2 Process for preparation of anhydrous azithromycin
05/28/2003EP1313742A1 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
05/28/2003EP1313740A1 Prodrugs of imidazopyridine derivatives
05/28/2003EP1313739A1 Alkylated imidazopyridine derivatives
05/28/2003EP1313738A1 Process for the preparation and purification of thiol-containing maytansinoids
05/28/2003EP1313737A1 Novel guanidino derivatives as inhibitors of cell adhesion
05/28/2003EP1313736A2 Condensed pyrazindione derivatives
05/28/2003EP1313734A2 Aza heterocyclic derivatives and their therapeutic use
05/28/2003EP1313733A1 Pyrazolopyridine compound and pharmaceutical use thereof
05/28/2003EP1313732A1 Oxindole derivatives
05/28/2003EP1313731A1 Thiazolidine derivatives and its use as antifungal agent
05/28/2003EP1313728A1 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors
05/28/2003EP1313727A1 Quinazoline derivatives
05/28/2003EP1313726A1 Quinoline derivatives having vegf inhibiting activity
05/28/2003EP1313725A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313720A1 N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
05/28/2003EP1313718A2 Inhibitors of copper-containing amine oxidases
05/28/2003EP1313717A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313716A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313715A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
05/28/2003EP1313714A1 Valsartan salts
05/28/2003EP1313713A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313709A1 Pyrazolyl biphenyl carboxamides
05/28/2003EP1313708A1 Quinoline antibacterial compounds and methods of use thereof
05/28/2003EP1313707A1 Quinoline derivatives as anti-inflammation agents
05/28/2003EP1313706A1 Method for synthesizing flosequinan from 4-fluoroanthranilic acid
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313703A1 Prodrugs to nmda receptor ligands
05/28/2003EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
05/28/2003EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
05/28/2003EP1313699A1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
05/28/2003EP1313697A2 Immunoregulatory compounds, derivatives thereof and their use
05/28/2003EP1313695A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
05/28/2003EP1313514A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
05/28/2003EP1313511A2 Testosterone ester formulation for human use
05/28/2003EP1313510A2 Novel pharmaceutical composition
05/28/2003EP1313509A2 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents
1 ... 5454 5455 5456 5457 5458 5459 5460 5461 5462 5463 5464 5465 5466 5467 5468 5469 5470 5471 5472 5473 5474 ... 7860